<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03568292</url>
  </required_header>
  <id_info>
    <org_study_id>0S-17-10</org_study_id>
    <secondary_id>NCI-2018-00759</secondary_id>
    <secondary_id>0S-17-10</secondary_id>
    <secondary_id>P30CA014089</secondary_id>
    <nct_id>NCT03568292</nct_id>
  </id_info>
  <brief_title>Virtual Reality in Reducing Pain and Anxiety in Cancer Participants Undergoing Painful Procedures</brief_title>
  <official_title>Effects of Virtual Reality on Pain and Anxiety in Cancer Patients Undergoing Painful Procedures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Southern California</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Virtually Strong, LLC</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Southern California</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This trial studies how well virtual reality (VR) works in reducing pain and anxiety in cancer
      participants undergoing bone marrow biopsy or lumbar puncture. Virtual reality may impact
      pain and anxiety during and after the procedure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PRIMARY OBJECTIVES:

      I. To determine the feasibility of VR in patients undergoing procedural intervention.

      SECONDARY OBJECTIVES:

      I. To estimate differences between the two arms in terms of pain and anxiety. II. To document
      any adverse events that could possibly be attributed to the VR intervention.

      EXPLORATORY OBJECTIVES:

      I. Explore the use of biomarkers as a tool to reflect the impact of intervention.

      OUTLINE: Participants are randomized to 1 of 2 arms.

      ARM I: Participants undergo VR intervention peri-procedure (bone marrow biopsy or lumbar
      puncture) lasting until completion of the procedure.

      ARM II: Participants receive standard of care during procedure (bone marrow biopsy or lumbar
      puncture).
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 1, 2020</start_date>
  <completion_date type="Anticipated">May 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain as assessed according to a visual analog scale (VAS)</measure>
    <time_frame>Up to 1 year</time_frame>
    <description>A visual analogue pain scale is a validated pain measure. A 10 centimeter horizontal line with a 0 (no pain) on the far left and 10 (worst possible pain) on the far right. Participants rate pain intensity by drawing a mark on the line. Pain intensity is obtained by measuring from the 0 to the participant's mark on the line, yielding a score from 0 to 10.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Anxiety</measure>
    <time_frame>Up to 1 year</time_frame>
    <description>Will be assessed by the State-Trait Anxiety Inventory.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Malignant Neoplasm</condition>
  <arm_group>
    <arm_group_label>Arm I: Virtual Reality</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants receive the VR intervention during bone marrow biopsy or lumbar puncture lasting until completion of the procedure. Participants will be trained to use VR equipment prior to the bone marrow biopsy or lumbar puncture. The headset will cover both eyes with a strap along the back to hold the headset in place. The headset will be attached by a wire to a laptop which will power the headset and provide content. A remote control will be available for assistance in setting up or stopping the content in the case of an event. The VR content will consist of meditation and relaxing techniques through visual and auditory input which can last up to one hour. There will be minimal stimulatory effort to decrease excess movement for the procedure.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm II: No Virtual Reality</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants receive standard of care during bone marrow biopsy or lumbar puncture.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Best Practice</intervention_name>
    <description>Receive standard of care</description>
    <arm_group_label>Arm II: No Virtual Reality</arm_group_label>
    <other_name>standard of care</other_name>
    <other_name>standard therapy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Laboratory Biomarker Analysis</intervention_name>
    <description>Correlative studies</description>
    <arm_group_label>Arm I: Virtual Reality</arm_group_label>
    <arm_group_label>Arm II: No Virtual Reality</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Oculus Rift Headset</intervention_name>
    <description>Subject wears headset for virtual reality intervention during bone marrow biopsy or lumbar puncture procedure</description>
    <arm_group_label>Arm I: Virtual Reality</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Questionnaire Administration</intervention_name>
    <description>Ancillary studies</description>
    <arm_group_label>Arm I: Virtual Reality</arm_group_label>
    <arm_group_label>Arm II: No Virtual Reality</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient has been diagnosed with any cancer

          -  Patient is currently hospitalized and receiving treatment for a primary or secondary
             cancer at University of Southern California (USC) Norris Comprehensive Cancer Center
             and Hospital

          -  Patient is undergoing a bone marrow biopsy or lumbar puncture

        Exclusion Criteria:

          -  Inability to sign informed assent and/or consent

          -  Patient with an underlying diagnosis of epilepsy, dementia, Parkinson?s disease,
             primary central nervous system malignancy, brain metastasis, underlying inflammatory
             or infectious central nervous system disorder, inner ear infection, history of
             vertigo, baseline visual or hearing impairment, macular degeneration, untreated
             glaucoma, implantable medical devices or any medical condition that investigator deems
             contraindicated

          -  Patient with an underlying chronic pain disorder, anxiety disorder, depressive
             disorder, or other psychiatric illness unspecified

          -  Patient with active Clostridium difficile infection

          -  Patient on any acute (within last &lt; 24 hour [hr]) or chronic pain medication (opioid,
             nonsteroidal anti-inflammatory drug [NSAID], steroid)

          -  Patient on chronic steroids &gt; 10 mg prednisone equivalent daily or other
             immunosuppressant &gt; 1 week

          -  Patient who is post bone marrow transplant

          -  Patient with a body mass index (BMI) &gt; 35
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jacek Pinski, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Southern California</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Zeno Ashai</last_name>
    <phone>323-865-0463</phone>
    <email>zeno.ashai@med.usc.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>USC / Norris Comprehensive Cancer Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90033</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Jacek Pinski</last_name>
      <phone>323-865-3929</phone>
      <email>pinski_j@ccnt.usc.edu</email>
    </contact>
    <investigator>
      <last_name>Jacek Pinski</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>June 14, 2018</study_first_submitted>
  <study_first_submitted_qc>June 14, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 26, 2018</study_first_posted>
  <last_update_submitted>March 25, 2020</last_update_submitted>
  <last_update_submitted_qc>March 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 26, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

